Harvest One (TSXV: HVST) Investor Dashboard, page-35

This is from April last year. Explains it was MMJ Bioscience who tried to list in Canada not MMJ PhytoTech. PhytoTech ended up acquiring Bioscience however Andreas is from Bioscience and could explain the desire to list in Canada via Harvest One.


TSX Venture Exchange gained 5.53 points to 657.44 Tuesday. Scott Hayduk's NEX shell, Tilting Capital Corp. (TLL), resumed trading today and was the sixth most active stock on the exchange. The stock dropped 11.5 cents to four cents on 2.69 million shares, as shareholders rushed to the exits. Tilting Capital had been halted since April, 2014, when it announced a plan to acquire MMJ Bioscience Inc., an aspiring medical marijuana grower with production facilities in Duncan, B.C., and Lucky Lake, Sask. Under Tilting and MMJ's deal, MMJ needed to sell a $3.5-million private placement to raise money for the resulting issuer. Unfortunately for Tilting, MMJ decided to go public instead through PhytoTech Medical Ltd., a shell on the Australian Securities Exchange that did not require MMJ to raise any money. Now, MMJ trades on the ASX as MMJ Phytotech Ltd. It last closed at 24 Australian cents. MMJ Phytotech is still awaiting its medical marijuana production licence in Canada, but it has operations elsewhere. In August, 2015, it launched its sales website for a cannabidiol pill called Sativol, which is marketed as a dietary supplement in the European Union.